CDK2 and cancer: CCND1, CCNA2, CDK2, CDK4 and EG5, part of the main regulatory genes of cell cycle control and progression, also closely linked to cancer hallmarks and their related genes (as MET and c-MYC)23–26, were all down-regulated by indolin-3-one in a dose and time-dependent manner.